IC
VKTX icon

Ikarian Capital’s Viking Therapeutics VKTX Stock Holding History

Ikarian Capital’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$379K Hold
9,717
– – 0.04% 132
2026
Q1 		$316K Hold
9,717
– – 0.03% 132
2025
Q4 		$342K Sell
9,717
-283
-3% -$10K 0.03% 146
2025
Q3 		$263K Sell
10,000
-90,000
-90% -$2.68M 0.03% 145
2025
Q2 		$2.65M Buy
100,000
+50,000
+100% +$1.32M 0.51% 57
2025
Q1 		$1.21M Buy
+50,000
New +$1.58M 0.15% 90
2024
Q3 		– Sell
-138,262
Closed -$7.33M – 171
2024
Q2 		$7.33M Buy
+138,262
New +$9.06M 1.28% 24
2023
Q2 		– Sell
-43,156
Closed -$719K – 156
2023
Q1 		$719K Sell
43,156
-160,000
-79% -$1.65M 0.16% 87
2022
Q4 		$1.91M Sell
203,156
-260,000
-56% -$1.16M 0.46% 42
2022
Q3 		$1.26M Sell
463,156
-372,119
-45% -$1.22M 0.25% 64
2022
Q2 		$2.41M Buy
835,275
+302,846
+57% +$749K 0.44% 52
2022
Q1 		$1.6M Buy
532,429
+31,787
+6% +$114K 0.21% 78
2021
Q4 		$2.3M Hold
500,642
– – 0.34% 57
2021
Q3 		$3.14M Sell
500,642
-24,112
-5% -$149K 0.22% 102
2021
Q2 		$3.14M Sell
524,754
-200,000
-28% -$1.19M 0.25% 94
2021
Q1 		$4.58M Buy
+724,754
New +$5.1M 0.15% 125
2020
Q3 		– Sell
-1,159
Closed -$8K – 210
2020
Q2 		$8K Sell
1,159
-125,000
-99% -$830K ﹤0.01% 164
2020
Q1 		$590K Hold
126,159
– – 0.04% 131
2019
Q4 		$1.01M Buy
+126,159
New +$920K 0.16% 80

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Ikarian Capital's VKTX Position: Q2 2026 in Review

Ikarian Capital held its Viking Therapeutics (VKTX) position steady in Q2 2026 at 9,717 shares worth $379K. The position accounts for 0.04% of the portfolio, ranked #132.

Ikarian Capital first reported a position in VKTX in Q4 2019 and has held it in 19 quarters since. The position peaked at $7.33M in Q2 2024. 434 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Ikarian Capital held 9,717 shares of Viking Therapeutics worth $379K as of Q2 2026.
  • Ikarian Capital left its Viking Therapeutics share count unchanged in Q2 2026.
  • Viking Therapeutics made up 0.04% of Ikarian Capital's portfolio in Q2 2026, its #132 holding.
  • Ikarian Capital first reported a position in Viking Therapeutics in Q4 2019 and has held it in 19 quarters since.
  • Ikarian Capital's Viking Therapeutics position peaked at $7.33M in Q2 2024.
  • 434 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.